Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DDMAC Adds New Consumer Group To Handle Ad Load; More Marketing Briefs

Executive Summary

A fresh look at DTC: CDER's Division of Drug Marketing, Advertising & Communication is creating a second direct-to-consumer review group to address the ad division's growing review burden. "It's just important to try to address the increased workload that we're getting and to have two group leaders to help to make sure that our advisory comments to you are not getting bottlenecked somewhere," DTC Review Group Leader Melissa Moncavage says at FDLI's Sept. 18-19 advertising and promotion conference. The DTC review groups will be led by Moncavage and Lead Consumer Safety Officer Christine Smith, effective immediately. DDMAC will retain its four review groups to evaluate professional advertising. Funding to help meet DDMAC's workload, which has increased with the PhRMA guideline's recommendation for DTC preclearance, has come up in PDUFA negotiations...
Advertisement
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS047591

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel